Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Juno Therapeutics
Juno Therapeutics is developing cell-based cancer immunotherapies.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
Adaptimmune
Adaptimmune develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Prelude Therapeutics
Prelude Therapeutics develops novel therapies to target key drivers of cancer cell growth, survival, and resistance.
Sector
Subsector
Keywords
Location
total rounds
total raised
Ziopharm oncology
ZIOPHARM Oncology is a biotechnology company developing gene therapy, cell therapy, and cancer immunotherapy products.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds5
Number of Funding Rounds
Money Raised
Their latest funding was raised on 23.10.2023. Their latest investor Arix Bioscience. Their latest round Post-IPO Equity
Arix Bioscience
Arix Bioscience is a global healthcare and life science company.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
New Leaf Venture Partners
New Leaf Venture Partners is a venture capital firm that invests in healthcare technology companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
OrbiMed
OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors19
Number of lead investors
Number of investors
Arix Bioscience
Arix Bioscience is a global healthcare and life science company.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
OrbiMed
OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
New Leaf Venture Partners
New Leaf Venture Partners is a venture capital firm that invests in healthcare technology companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders2
Patrick Baeuerle
Patrick A. Baeuerle, Ph.D., joined MPM in 2015. Patrick is responsible for the development of BiTE antibody Blincyto® (blinatumomab; AMG 103) which was approved within three months by the US FDA for therapy of relapsed/refractory acute lymphoblastic leukemia. He also spearheaded the development of the BiTE technology, the industry- leading T-cell engaging antibody platform.
current job
Patrick Baeuerle
Luke Evnin
Luke Evnin is the Co-Founder and Managing Director of MPM Capital.
current job
Luke Evnin
Employee Profiles24
Activity
Recent News9
The graph reveals the ratio (%) of positive news articles in a chosen time range